Skip to main content
. 2022 Sep 17;29(3):570–582. doi: 10.3390/pathophysiology29030044

Figure 5.

Figure 5

Diagram of decision trees for diagnostic evaluation of MS (left) and RRMS (right) based on CBS. Left—collapsed evaluation suggests that using CBS as a biomarker, MS can be discriminated from controls with 79 and 82% accuracy. Right—uncollapsed decision tree shows that CBS can also be used to discriminate RRMS from healthy controls with 72 and 75% accuracy, respectively.